IP Library Granted Patent US 7,195,013
Granted Patent B2
US 7,195,013 · App. 10/765,318 · Granted Mar 27, 2007

Systems and methods for modulating autonomic function

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,195,013
App. No.
10/765,318
Granted
Mar 27, 2007
Kind
B2
Abstract

In one embodiment, a method for modulating a person's autonomic function comprises interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event. The person is permitted to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to transiently decrease intrathoracic pressure and thereby modulate the person's autonomic function.

Claims (32)

1. A method for modulating a person's autonomic function, the method comprising:

interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event;

permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to transiently decrease intrathoracic pressure and thereby modulate the person's autonomic functions;

wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to about −30 cm H2O.

2. A method as in claim 1 , further comprising coupling at least one physiological sensor to the patient to monitor at least one physiological parameter of the person while breathing through the valve system, and varying the actuating pressure based on the monitored physiological parameter.

3. A method as in claim 1 , further comprising setting the actuating pressure of the valve to be in the range from about −3 cm H2O to about −12 cm H2O for flow rates between about 30 to about 50 liters per minute.

4. A method as in claim 1 , wherein during inhalation the valve system functions to decrease the person's heart rate and peripheral vascular tone.

5. A method as in claim 1 , wherein during inhalation the valve system functions to increase blood flow back to the right heart of the person, thereby enhancing vital organ perfusion and function.

6. A method as in claim 1 , wherein during inhalation the valve system functions to increase heart rate variability.

7. A method as in claim 1 , wherein the valve system is incorporated into a facial mask or a mouthpiece, and further comprising coupling the facial mask or the mouthpiece to the person's face.

8. A method as in claim 1 , wherein during inhalation the valve system functions to reduce the person's anxiety level.

9. A method as in claim 1 , wherein during inhalation the valve system functions to treat shock secondary to hypovolemia, sepsis and heart failure.

10. A method as in claim 1 , wherein during inhalation the valve system functions to treat states of hypo-perfusion that are selected from a group consisting of wound healing, stroke and diseases where blood flow is compromised, wherein at least one of the diseases comprises coronary artery disease.

11. A method as in claim 1 , wherein during inhalation the valve system functions to improve blood flow to the muscles and brain, thereby reducing heart rate and enhancing recovery from physical exertion.

12. A method for assisting a person in recovering from physical exertion, the method comprising:

interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event;

permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to improve blood flow to the muscles and brain, and to reduce the person's heart rates;

wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to about −30 cm H2O.

13. A method for treating a person, the method comprising:

interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event;

permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to treat hypotension, shock secondary to hypovolemia, sepsis and heart failures;

wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to about −30 cm H2O.

14. A method for modulating a person's autonomic function, the method comprising:

interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event;

permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to transiently decrease intrathoracic pressure and thereby modulate the person's autonomic function;

wherein during inhalation the valve system functions to decrease sympathetic tones;

wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to about −30 cm H2O.

15. A method for modulating a person's autonomic function, the method comprising:

interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event;

permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to transiently decrease intrathoracic pressure and thereby modulate the person's autonomic function;

wherein during inhalation the valve system functions to treat sleep disorders, wherein at least one of the sleep disorders comprises apnea;

wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to about −30 cm H2O.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: ADVANCED CIRCULATORY SYSTEMS INC
To: ZOLL MEDICAL CORPORATION
Reel/Frame 042347/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2004
From: LURIE, KEITH G.
To: ADVANCED CIRCULATORY SYSTEMS, INC.
Reel/Frame 015480/0339 →